James Connors, MD
MOHS-Micrographic Surgery · St Petersburg, FLNPI 1548255250
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 61.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $9,392 and has fallen 88.0% since, to $1,127 in 2025.
Across 317 payments — averaging $46.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$9K
- Novartis$1K
- AbbVie$747
- Sun Pharmaceutical Industries Inc.$688
- Amgen$584
- Regeneron Healthcare Solutions, Inc.$450
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$7,80053%
- Travel & lodging$5344%
- Food & beverage$6,24543%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 39 | $9,040 |
| Novartis | 53 | $1,024 |
| AbbVie | 37 | $747 |
| Sun Pharmaceutical Industries Inc. | 41 | $688 |
| Amgen | 28 | $584 |
| Regeneron Healthcare Solutions, Inc. | 17 | $450 |
| Sanofi | 19 | $442 |
| Johnson & Johnson | 11 | $222 |
| Lilly USA, LLC | 7 | $201 |
| Organogenesis Inc. | 5 | $173 |
| LEO Pharma Inc. | 7 | $146 |
| Bristol Myers Squibb | 12 | $132 |
| Almirall LLC | 5 | $128 |
| Kerecis Limited | 9 | $118 |
| Boehringer Ingelheim | 4 | $109 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $80 |
| Pfizer | 5 | $78 |
| Incyte Corporation | 3 | $50 |
| Galderma Laboratories, L.p. | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Dermavant Sciences, Inc. | 1 | $21 |
| DUSA Pharmaceuticals, Inc. | 1 | $21 |
| Krystal Biotech Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Dermira, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erivedge$8,564
How this compares
$14,596 in reported general payments places this provider in the 85th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 12 | $74 |
| Cephalexin | 12 | $39 |
| Lorazepam | 17 | $17 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in St Petersburg
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
- Kenneth WallaceOcala$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.